MedTrace Logo

Hormones and Reduction in Co-users of Marijuana and Nicotine

NCT02579421 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2020-06-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the role of progesterone (a naturally occurring hormone found in both men and women) on reducing marijuana use. The investigators will see if progesterone effects impulsivity, withdrawal, mood and stress during marijuana cessation.

Conditions

  • Marijuana Dependence

Interventions

DRUG

Progesterone

generic progesterone

DRUG

placebo

placebo

Sponsors & Collaborators

Principal Investigators

  • Sharon Allen, Ph.D,M.D. · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-07-27
Completion
2017-07-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579421 on ClinicalTrials.gov